Mega Lifesciences PCL
SET:MEGA

Watchlist Manager

Mega Lifesciences PCL

SET:MEGA

Watchlist

Dividends

Discount Rate

Price: 36.5 THB -2.67% Market Closed

Market Cap: 31.8B THB

Have any thoughts about
Mega Lifesciences PCL?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Estee Lauder Companies Inc NYSE:EL	Consumer products
US	Exxon Mobil Corp NYSE:XOM	Energy
US	Church & Dwight Co Inc NYSE:CHD	Consumer products
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	American Express Co NYSE:AXP	Financial Services
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	3M Co NYSE:MMM	Industrial Conglomerates
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Target Corp NYSE:TGT	Retail
US	Walt Disney Co NYSE:DIS	Media
US	Mueller Industries Inc NYSE:MLI	Machinery
US	PayPal Holdings Inc NASDAQ:PYPL	Technology

Add Price Alert

Price Target:

Last Price: 36.5 THB

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

MEGA Alert

Mega Lifesciences PCL

36.5

-1.0 (-2.67%)

52 Week Range	35.75 44
Price Target

We'll email you a reminder when the closing price reaches THB.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Estee Lauder Companies Inc NYSE:EL	US
	Exxon Mobil Corp NYSE:XOM	US
	Church & Dwight Co Inc NYSE:CHD	US
	Pfizer Inc NYSE:PFE	US
	American Express Co NYSE:AXP	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	3M Co NYSE:MMM	US
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Target Corp NYSE:TGT	US
	Walt Disney Co NYSE:DIS	US
	Mueller Industries Inc NYSE:MLI	US
	PayPal Holdings Inc NASDAQ:PYPL	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Mega Lifesciences PCL

What unique competitive advantages
does Mega Lifesciences PCL hold over its rivals?

What risks and challenges
does Mega Lifesciences PCL face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Mega Lifesciences PCL.

What unique competitive advantages
does Mega Lifesciences PCL hold over its rivals?

What risks and challenges
does Mega Lifesciences PCL face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Mega Lifesciences PCL.

Provide P/S
for Mega Lifesciences PCL.

Provide P/E
for Mega Lifesciences PCL.

Provide P/OCF
for Mega Lifesciences PCL.

Provide P/FCFE
for Mega Lifesciences PCL.

Provide P/B
for Mega Lifesciences PCL.

Provide EV/S
for Mega Lifesciences PCL.

Provide EV/GP
for Mega Lifesciences PCL.

Provide EV/EBITDA
for Mega Lifesciences PCL.

Provide EV/EBIT
for Mega Lifesciences PCL.

Provide EV/OCF
for Mega Lifesciences PCL.

Provide EV/FCFF
for Mega Lifesciences PCL.

Provide EV/IC
for Mega Lifesciences PCL.

Show me price targets
for Mega Lifesciences PCL made by professional analysts.

What are the Revenue projections
for Mega Lifesciences PCL?

How accurate were the past Revenue estimates
for Mega Lifesciences PCL?

What are the Net Income projections
for Mega Lifesciences PCL?

How accurate were the past Net Income estimates
for Mega Lifesciences PCL?

What are the EPS projections
for Mega Lifesciences PCL?

How accurate were the past EPS estimates
for Mega Lifesciences PCL?

What are the EBIT projections
for Mega Lifesciences PCL?

How accurate were the past EBIT estimates
for Mega Lifesciences PCL?

Compare the revenue forecasts
for Mega Lifesciences PCL with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Mega Lifesciences PCL and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Mega Lifesciences PCL against its competitors.

Analyze the profit margins
(gross, operating, and net) of Mega Lifesciences PCL compared to its peers.

Compare the P/E ratios
of Mega Lifesciences PCL against its peers.

Discuss the investment returns and shareholder value creation
comparing Mega Lifesciences PCL with its peers.

Analyze the financial leverage
of Mega Lifesciences PCL compared to its main competitors.

Show all profitability ratios
for Mega Lifesciences PCL.

Provide ROE
for Mega Lifesciences PCL.

Provide ROA
for Mega Lifesciences PCL.

Provide ROIC
for Mega Lifesciences PCL.

Provide ROCE
for Mega Lifesciences PCL.

Provide Gross Margin
for Mega Lifesciences PCL.

Provide Operating Margin
for Mega Lifesciences PCL.

Provide Net Margin
for Mega Lifesciences PCL.

Provide FCF Margin
for Mega Lifesciences PCL.

Show all solvency ratios
for Mega Lifesciences PCL.

Provide D/E Ratio
for Mega Lifesciences PCL.

Provide D/A Ratio
for Mega Lifesciences PCL.

Provide Interest Coverage Ratio
for Mega Lifesciences PCL.

Provide Altman Z-Score Ratio
for Mega Lifesciences PCL.

Provide Quick Ratio
for Mega Lifesciences PCL.

Provide Current Ratio
for Mega Lifesciences PCL.

Provide Cash Ratio
for Mega Lifesciences PCL.

What is the historical Revenue growth
over the last 5 years for Mega Lifesciences PCL?

What is the historical Net Income growth
over the last 5 years for Mega Lifesciences PCL?

What is the current Free Cash Flow
of Mega Lifesciences PCL?

Discuss the annual earnings per share (EPS)
trend over the past five years for Mega Lifesciences PCL.

EV/EBITDA
Enterprise Value to EBITDA

8.7

Current

11.8

Median

13.7

Industry

Lower than median

Lower than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA

8.7

Enterprise Value

28.5B THB

EBITDA

3.3B THB

All Countries

Forward Multiples

			Market Cap	EV/EBITDA
TH	M	Mega Lifesciences PCL SET:MEGA	31.8B THB	8.7
JP	N	Nichi-Iko Pharmaceutical Co Ltd TSE:4541	776 550.9T JPY	-5 459 134.4
US		Eli Lilly and Co NYSE:LLY	756.5B USD	48.6
UK		Dechra Pharmaceuticals PLC LSE:DPH	440.4B GBP	3 846.3
DK		Novo Nordisk A/S CSE:NOVO B	3.3T DKK	24.4
US		Johnson & Johnson NYSE:JNJ	364.1B USD	12
US		Merck & Co Inc NYSE:MRK	248.4B USD	10.4
CH		Roche Holding AG SIX:ROG	208.5B CHF	10.2
CH		Novartis AG SIX:NOVN	181.2B CHF	10
UK		AstraZeneca PLC LSE:AZN	159.6B GBP	169.4
IE	E	Endo International PLC LSE:0Y5F	146B USD	234.4

				EBITDA Growth
TH	M	Mega Lifesciences PCL SET:MEGA	Average EV/EBITDA: 437.4 8.7	14%
JP	N	Nichi-Iko Pharmaceutical Co Ltd TSE:4541	Negative Multiple: -5 459 134.4	N/A
US		Eli Lilly and Co NYSE:LLY	48.6	194%
UK		Dechra Pharmaceuticals PLC LSE:DPH	3 846.3	151%
DK		Novo Nordisk A/S CSE:NOVO B	24.4	86%
US		Johnson & Johnson NYSE:JNJ	12	13%
US		Merck & Co Inc NYSE:MRK	10.4	339%
CH		Roche Holding AG SIX:ROG	10.2	23%
CH		Novartis AG SIX:NOVN	10	8%
UK		AstraZeneca PLC LSE:AZN	169.4	60%
IE	E	Endo International PLC LSE:0Y5F	234.4	N/A

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward

EV/EBITDA

9.1

2-Years Forward

EV/EBITDA

8.3

3-Years Forward

EV/EBITDA

7.8

Mega Lifesciences PCL
SET:MEGA

EV/EBITDA
Enterprise Value to EBITDA

EV/EBITDA Forward Multiples

See Also

Company

Help

Tools

Stocks

Mega Lifesciences PCL SET:MEGA

EV/EBITDA Enterprise Value to EBITDA

EV/EBITDA Forward Multiples

See Also

Company

Help

Tools

Stocks

Mega Lifesciences PCL
SET:MEGA

EV/EBITDA
Enterprise Value to EBITDA